ES2099395T3 - Cicloalquilalquilaminas ligandos a los receptores sigma, su procedimiento de preparacion y su aplicacion terapeutica. - Google Patents

Cicloalquilalquilaminas ligandos a los receptores sigma, su procedimiento de preparacion y su aplicacion terapeutica.

Info

Publication number
ES2099395T3
ES2099395T3 ES93401959T ES93401959T ES2099395T3 ES 2099395 T3 ES2099395 T3 ES 2099395T3 ES 93401959 T ES93401959 T ES 93401959T ES 93401959 T ES93401959 T ES 93401959T ES 2099395 T3 ES2099395 T3 ES 2099395T3
Authority
ES
Spain
Prior art keywords
sigma
cyclalalkyl
alkylamines
receivers
linked
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93401959T
Other languages
English (en)
Inventor
Jean-Louis Junien
Alain Calvet
Henri Jacobelli
Francois Roman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut de Recherche Jouveinal
Original Assignee
Institut de Recherche Jouveinal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut de Recherche Jouveinal filed Critical Institut de Recherche Jouveinal
Application granted granted Critical
Publication of ES2099395T3 publication Critical patent/ES2099395T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
    • C07C211/38—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
    • C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C225/18—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings the carbon skeleton containing also rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/44—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups being part of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/12—One of the condensed rings being a six-membered aromatic ring the other ring being at least seven-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicinal Preparation (AREA)

Abstract

NUEVAS CICLOALQUILALQUILAMINAS LIGANDOS A LOS RECEPTORES SIGMA DE FORMULA (I), EN LA CUAL, R1 ES H O ALQUIL INFERIOR; X E Y SON H, OH, ALQUIL INFERIOR, ALCOXI INFERIOR, HALOGENO O NITRILO; V1 Y V2 FORMAN JUNTOS UN DOBLE ENLACE UNIDO A UN OXIGENO O A UN RADICAL HIDROXIIMINO, O ESTAN UNIDOS A UNA CADENA ETILENO DIOXI; A ES UN ENLACE DE VALENCIA, UN OXIGENO, UN GRUPO METILENO O ETILENO; M ES 0, 1 O 2 Y N VARIA DE 1 A 5. MEDICAMENTO SICOTROPO TAMBIEN UTIL EN GASTROENTEROLOGIA.
ES93401959T 1992-07-31 1993-07-28 Cicloalquilalquilaminas ligandos a los receptores sigma, su procedimiento de preparacion y su aplicacion terapeutica. Expired - Lifetime ES2099395T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR929209536A FR2694287B1 (fr) 1992-07-31 1992-07-31 Nouvelles cycloalkylalkylamines ligands aux récepteurs sigma, leur procédé de préparation et leur application en thérapeutique.

Publications (1)

Publication Number Publication Date
ES2099395T3 true ES2099395T3 (es) 1997-05-16

Family

ID=9432517

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93401959T Expired - Lifetime ES2099395T3 (es) 1992-07-31 1993-07-28 Cicloalquilalquilaminas ligandos a los receptores sigma, su procedimiento de preparacion y su aplicacion terapeutica.

Country Status (16)

Country Link
US (1) US5326784A (es)
EP (1) EP0581677B1 (es)
JP (1) JP3179942B2 (es)
KR (1) KR100314102B1 (es)
AT (1) ATE147373T1 (es)
AU (1) AU660829B2 (es)
CA (1) CA2101575C (es)
DE (1) DE69307210T2 (es)
ES (1) ES2099395T3 (es)
FI (1) FI112650B (es)
FR (1) FR2694287B1 (es)
MX (1) MX9304578A (es)
NO (1) NO179512C (es)
NZ (1) NZ248279A (es)
TW (1) TW230190B (es)
ZA (2) ZA935482B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5504253A (en) * 1994-07-15 1996-04-02 Nps Pharmaceuticals, Inc. Amine preparation
US5648541A (en) * 1995-09-28 1997-07-15 Nps Pharmaceuticals, Inc. Chiral reductions of imines leading to the syntheses of optically active amines
FR2751645B1 (fr) * 1996-07-29 1998-12-24 Sanofi Sa Amines pour la fabrication de medicaments destines a empecher la proliferation de cellules tumorales
US20230364033A1 (en) 2020-09-17 2023-11-16 Meletios Therapeutics Compounds for treating virus infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0038388A1 (en) * 1980-04-17 1981-10-28 Exxon Research And Engineering Company Foam dispensing nozzle and method and apparatus for transporting laminates comprising a foamable plastics material using a nozzle
JP2931986B2 (ja) * 1989-02-17 1999-08-09 武田薬品工業株式会社 アラルキルアミン誘導体
EP0507863A4 (en) * 1989-12-28 1993-07-07 Virginia Commonwealth University Sigma receptor ligands and the use thereof

Also Published As

Publication number Publication date
ZA935482B (en) 1994-02-28
EP0581677A1 (fr) 1994-02-02
MX9304578A (es) 1994-01-31
NO932728D0 (no) 1993-07-29
NO179512C (no) 1996-10-23
ZA935434B (en) 1994-02-22
JP3179942B2 (ja) 2001-06-25
AU4427993A (en) 1994-02-03
FI112650B (fi) 2003-12-31
NO932728L (no) 1994-02-01
KR100314102B1 (ko) 2002-08-28
AU660829B2 (en) 1995-07-06
US5326784A (en) 1994-07-05
EP0581677B1 (fr) 1997-01-08
CA2101575A1 (en) 1994-02-01
NO179512B (no) 1996-07-15
KR940005550A (ko) 1994-03-21
TW230190B (es) 1994-09-11
FI933403A0 (fi) 1993-07-29
DE69307210T2 (de) 1997-05-15
FR2694287B1 (fr) 1994-09-16
DE69307210D1 (de) 1997-02-20
FI933403A (fi) 1994-02-01
ATE147373T1 (de) 1997-01-15
CA2101575C (en) 2004-03-23
NZ248279A (en) 1995-12-21
FR2694287A1 (fr) 1994-02-04
JPH06206851A (ja) 1994-07-26

Similar Documents

Publication Publication Date Title
ES8404993A1 (es) Procedimiento para preparar derivados de piridina
FI823923A0 (fi) Antifibrinolytiskt aktiva foereningar
ATE212666T1 (de) Tnf-liganden
SE8600413L (sv) Nytt lekemedel och sett att framstella detsamma
ES2099395T3 (es) Cicloalquilalquilaminas ligandos a los receptores sigma, su procedimiento de preparacion y su aplicacion terapeutica.
IE56051B1 (en) Sulfur-containing indole derivatives
DE3363593D1 (en) 2-nitro-ethene diamines, process for their preparation and their use as medicines
ATE41772T1 (de) Polymethoxybenzyl-piperazin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen.
DE68911237D1 (de) Nichtionische Trijodbenzin-Verbindungen und diese enthaltende Kontrastmittel.
FI894068A0 (fi) Sulfonamider med tetrazolylrest, foerfarande foer deras tillverkning och laekemedel.
DK323183A (da) Fremgangsmaade til fremstilling af cephalosporinderivater
AU563923B2 (en) Tetrahydro-beta-carboline derivatives
DE69011235D1 (de) Derivate von N-(Vincristinyl-23) und N-(Noranhydro-5-vinblastinyl-23) von Amino-1-methylphosphonsäure, ihre Verfahren zur Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 581677

Country of ref document: ES